Hiromi Miwa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiromi Miwa has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Naoki Hayakawa
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
5 shared publicationsShinya Ichihara
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
5 shared publicationsShunichi Kushida
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
5 shared publicationsYasuyuki Tsuchida
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
4 shared publicationsKotaro Miyaji
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
3 shared publicationsSatoshi Hirano
Department of Cardiovascular Medicine, Asahi General Hospital, Chiba, Japan
3 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 88
Clinical feasibility of primary retrograde endovascular therapy via trans-ankle intervention: a retrospective single-center study
Background: Trans-ankle intervention (TAI) through retrograde distal access via below-the-knee and below-the-ankle arteries has been increasingly reported as an alternative approach for the treatment of femoropopliteal (FP) lesions. Although previous studies have described the procedural success of this strategy, its clinical feasibility and post-procedural outcomes remain insufficiently characterized. Methods: In this retrospective single-center study, the data from 33 patients with 36 FP lesions who underwent endovascular therapy (EVT) between January 2024 and January 2025 were analyzed. The primary endpoint was procedural success. The secondary endpoints were clinical worsening of lower-limb ischemia within 30 days, 1-year freedom from clinically driven target lesion revascularization (CD-TLR), and procedural complications. The risk of post-procedure access vessel occlusion was also investigated. Results: TAI was performed via access sites ranging from the anterior tibial artery (ATA) to the dorsalis pedis artery in all patients. Procedural success was achieved in all cases, and the rate of 1-year freedom from CD-TLR was 91.8%. All patients had FP lesions, including three cases up to the iliac artery. Forty-two percent was chronic total occlusion, and EVT of the ATA was required in 42% of the cases to establish the access route. Ten cases (27.8%) were approached via the occluded pre-ATA, and 15 (41.7%) required intervention to approach the vessel. The average number of pre-procedural and post-procedural below-the-knee artery runoff vessels was 2.4 and 2.75, respectively. No patients showed clinical worsening within 30 days. The risk factors for ATA occlusion were hemodialysis, ATA intervention, and approach via the occluded ATA. Conclusions: TAI may represent a feasible result, especially for selected FP lesions. Although no clinical worsening was observed, an increased risk of postoperative ATA occlusion existed in patients on hemodialysis and those with access site atherosclerosis requiring ATA intervention. However, in these high-risk populations, this limitation may potentially be overcome by an approach through the occluded ATA.
- 16 July 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 88
Open AccessClinical feasibility of primary retrograde endovascular therapy via trans-ankle intervention: a retrospective single-center study
Background: Trans-ankle intervention (TAI) through retrograde distal access via below-the-knee and below-the-ankle arteries has been increasingly reported as an alternative approach for the treatment of femoropopliteal (FP) lesions. Although previous studies have described the procedural success of this strategy, its clinical feasibility and post-procedural outcomes remain insufficiently characterized. Methods: In this retrospective single-center study, the data from 33 patients with 36 FP lesions who underwent endovascular therapy (EVT) between January 2024 and January 2025 were analyzed. The primary endpoint was procedural success. The secondary endpoints were clinical worsening of lower-limb ischemia within 30 days, 1-year freedom from clinically driven target lesion revascularization (CD-TLR), and procedural complications. The risk of post-procedure access vessel occlusion was also investigated. Results: TAI was performed via access sites ranging from the anterior tibial artery (ATA) to the dorsalis pedis artery in all patients. Procedural success was achieved in all cases, and the rate of 1-year freedom from CD-TLR was 91.8%. All patients had FP lesions, including three cases up to the iliac artery. Forty-two percent was chronic total occlusion, and EVT of the ATA was required in 42% of the cases to establish the access route. Ten cases (27.8%) were approached via the occluded pre-ATA, and 15 (41.7%) required intervention to approach the vessel. The average number of pre-procedural and post-procedural below-the-knee artery runoff vessels was 2.4 and 2.75, respectively. No patients showed clinical worsening within 30 days. The risk factors for ATA occlusion were hemodialysis, ATA intervention, and approach via the occluded ATA. Conclusions: TAI may represent a feasible result, especially for selected FP lesions. Although no clinical worsening was observed, an increased risk of postoperative ATA occlusion existed in patients on hemodialysis and those with access site atherosclerosis requiring ATA intervention. However, in these high-risk populations, this limitation may potentially be overcome by an approach through the occluded ATA.
- Open Access
- 22 April 2026
- Published by Springer Nature in Research Square
Clinical feasibility of endovascular therapy via trans-ankle intervention: a retrospective single-center study
Background Trans-ankle intervention (TAI) through retrograde distal access via below-the-knee and below-the-ankle arteries has been increasingly reported as an alternative approach for the treatment of femoropopliteal (FP) lesions. Although previous studies have described the procedural success of this strategy, its clinical feasibility and postprocedural outcomes remain insufficiently characterized. Methods In this retrospective single-center study, the data of 33 patients with 36 FP lesions who underwent endovascular therapy (EVT) between January 2024 and January 2025 were analyzed. The primary endpoint was procedural success. The secondary endpoints were clinical worsening of lower-limb ischemia within 30 days, 1-year freedom from clinically driven target lesion revascularization (CD-TLR), and procedural complications. The risk of post-procedure access vessel occlusion was also investigated. Results TAI via the anterior tibial artery (ATA) to the dorsalis pedis artery was performed in all patients. Procedural success was achieved in all cases, and the rate of 1-year freedom from CD-TLR was 91.8%. All patients had FP lesions, including three cases up to the iliac artery. 42% was chronic total occlusion, and EVT of the ATA was required in 42% of the cases to establish the access route. No patients showed clinical worsening within 30 days. The risk factors for ATA occlusion were hemodialysis, ATA intervention, and approach via the occluded ATA. Conclusions TAI showed feasible results, especially for FP lesions without serious complications. Although no clinical worsening was observed, an increased risk of postoperative ATA occlusion existed in patients on hemodialysis and those with access site atherosclerosis requiring ATA intervention. However, this limitation may potentially be surmounted by approaching through the occluded ATA.
- 22 April 2026
- Published by Springer Nature in Research Square
Open AccessClinical feasibility of endovascular therapy via trans-ankle intervention: a retrospective single-center study
Background Trans-ankle intervention (TAI) through retrograde distal access via below-the-knee and below-the-ankle arteries has been increasingly reported as an alternative approach for the treatment of femoropopliteal (FP) lesions. Although previous studies have described the procedural success of this strategy, its clinical feasibility and postprocedural outcomes remain insufficiently characterized. Methods In this retrospective single-center study, the data of 33 patients with 36 FP lesions who underwent endovascular therapy (EVT) between January 2024 and January 2025 were analyzed. The primary endpoint was procedural success. The secondary endpoints were clinical worsening of lower-limb ischemia within 30 days, 1-year freedom from clinically driven target lesion revascularization (CD-TLR), and procedural complications. The risk of post-procedure access vessel occlusion was also investigated. Results TAI via the anterior tibial artery (ATA) to the dorsalis pedis artery was performed in all patients. Procedural success was achieved in all cases, and the rate of 1-year freedom from CD-TLR was 91.8%. All patients had FP lesions, including three cases up to the iliac artery. 42% was chronic total occlusion, and EVT of the ATA was required in 42% of the cases to establish the access route. No patients showed clinical worsening within 30 days. The risk factors for ATA occlusion were hemodialysis, ATA intervention, and approach via the occluded ATA. Conclusions TAI showed feasible results, especially for FP lesions without serious complications. Although no clinical worsening was observed, an increased risk of postoperative ATA occlusion existed in patients on hemodialysis and those with access site atherosclerosis requiring ATA intervention. However, this limitation may potentially be surmounted by approaching through the occluded ATA.
- Open Access
- 1 July 2025
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 13
An effective method for percutaneous hemostasis of femoral artery by endovascular balloon occlusion via the occluded dorsal pedalis artery approach in a patient with restricted access site
Hemostasis of a large-diameter sheath is sometimes problematic, especially for patients with limited approach sites. Here, we describe an effective and safe endovascular method for hemostasis of the femoral artery via the dorsalis pedis artery. The patient was a 75-year-old man who was performing endovascular therapy via the left common femoral artery. A pseudoaneurysm developed, and it was treated via the right common femoral artery. He developed acute coronary syndrome 1 week later, and an intra-aortic balloon pump therapy was inserted via the right femoral artery. Neither radial artery was available, and the right brachial artery was punctured to perform coronary revascularization. When the intra-aortic balloon pump was to be removed, the right dorsal pedis artery was punctured, and hemostasis was achieved without any complications. We conclude that the trans-ankle intervention may be an effective and less invasive technique for percutaneous hemostatic procedures.
- 1 July 2025
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 13
Open AccessAn effective method for percutaneous hemostasis of femoral artery by endovascular balloon occlusion via the occluded dorsal pedalis artery approach in a patient with restricted access site
Hemostasis of a large-diameter sheath is sometimes problematic, especially for patients with limited approach sites. Here, we describe an effective and safe endovascular method for hemostasis of the femoral artery via the dorsalis pedis artery. The patient was a 75-year-old man who was performing endovascular therapy via the left common femoral artery. A pseudoaneurysm developed, and it was treated via the right common femoral artery. He developed acute coronary syndrome 1 week later, and an intra-aortic balloon pump therapy was inserted via the right femoral artery. Neither radial artery was available, and the right brachial artery was punctured to perform coronary revascularization. When the intra-aortic balloon pump was to be removed, the right dorsal pedis artery was punctured, and hemostasis was achieved without any complications. We conclude that the trans-ankle intervention may be an effective and less invasive technique for percutaneous hemostatic procedures.
- 5 December 2024
- Published by Springer Nature in Heart and Vessels
- Vol. 40 (7) , 647-654
One-year clinical outcomes of endovascular revascularization in patients with acute limb ischemia
Urgent revascularization should be performed to patients with acute limb ischemia (ALI) unless the ischemia is irreversible. In patients with severe ALI and multiple morbidities, surgical revascularization is not feasible; however, endovascular revascularization (EVR) may be an option. This study aimed to examine 1-year clinical outcomes of EVR in patients with ALI and determine prognostic factors. We retrospectively examined 90 EVR procedures performed in 81 patients with ALI between January 2018 and February 2024. The primary endpoint was 1-year amputation-free survival (AFS). Multivariable logistic regression was performed to identify predictors of 1-year AFS. Fifty-one procedures were performed for severe ALI (56.7%). Fifty-six patient were ambulatory at the time of procedures (62.2%). The 1-year AFS rate was 59.7%. Multivariable analysis revealed that hypertension (adjusted hazard ratio [aHR] 0.14; 95% confidence interval [CI], 0.05–0.47; P = 0.0007), presence of blood flow of both tibial arteries after EVR (aHR 0.19; 95% CI, 0.03–0.93; P = 0.04), and presence of arterial flow below the ankle after EVR (aHR 0.29; 95% CI, 0.09–0.84; P = 0.022) were independently associated with a higher AFS rate. Aortic plaque was independently associated with a lower AFS rate (aHR 3.98; 95% CI, 1.55–9.90; P = 0.048). EVR may be an acceptable treatment of ALI even in non-ambulatory patients and those with severe ALI. Achieving adequate blood flow of both tibial arteries and below the ankle by performing EVR may be important for improving patient outcomes.
- 5 December 2024
- Published by Springer Nature in Heart and Vessels
- Vol. 40 (7) , 647-654
One-year clinical outcomes of endovascular revascularization in patients with acute limb ischemia
Urgent revascularization should be performed to patients with acute limb ischemia (ALI) unless the ischemia is irreversible. In patients with severe ALI and multiple morbidities, surgical revascularization is not feasible; however, endovascular revascularization (EVR) may be an option. This study aimed to examine 1-year clinical outcomes of EVR in patients with ALI and determine prognostic factors. We retrospectively examined 90 EVR procedures performed in 81 patients with ALI between January 2018 and February 2024. The primary endpoint was 1-year amputation-free survival (AFS). Multivariable logistic regression was performed to identify predictors of 1-year AFS. Fifty-one procedures were performed for severe ALI (56.7%). Fifty-six patient were ambulatory at the time of procedures (62.2%). The 1-year AFS rate was 59.7%. Multivariable analysis revealed that hypertension (adjusted hazard ratio [aHR] 0.14; 95% confidence interval [CI], 0.05–0.47; P = 0.0007), presence of blood flow of both tibial arteries after EVR (aHR 0.19; 95% CI, 0.03–0.93; P = 0.04), and presence of arterial flow below the ankle after EVR (aHR 0.29; 95% CI, 0.09–0.84; P = 0.022) were independently associated with a higher AFS rate. Aortic plaque was independently associated with a lower AFS rate (aHR 3.98; 95% CI, 1.55–9.90; P = 0.048). EVR may be an acceptable treatment of ALI even in non-ambulatory patients and those with severe ALI. Achieving adequate blood flow of both tibial arteries and below the ankle by performing EVR may be important for improving patient outcomes.
- Open Access
- 5 October 2024
- Published by Springer Nature in CVIR Endovascular
- Vol. 7 (1) , 1-6
A novel bailout technique using myocardial biopsy forceps to grasp a dislodged angio-seal collagen with footplate
Background: Hemostatic devices are now frequently used in femoral artery punctures, and the Angio-Seal (Terumo, Tokyo, Japan) is one of the most commonly used devices for closure of the femoral artery because it provides rapid hemostasis. Although device failure rarely occurs, if the collagen falls into the femoral artery, it may lead to severe limb ischemia. Herein, we describe a case of a novel endovascular technique for the treatment of Angio-Seal arterial closure device failure. Case presentation: The patient in Case 1 was a 75-year-old man with severe left limb claudication. We used a contralateral antegrade approach and used the Angio-Seal for hemostasis. However, the Angio-Seal collagen and footplate dropped and stopped at the bifurcation of the superficial femoral artery and deep femoral artery. The collagen with the footplate was caught with myocardial biotome forceps (MBF) and pulled into the external iliac artery (EIA). The distal common femoral artery (CFA) was punctured, and we delivered a 10.0- × 80-mm stent (SMART®; Cordis, USA) to the EIA from the ipsilateral sheath. The stent was deployed at the EIA and crushed the collagen. The patient in Case 2 was an 88-year-old man with rest pain in the right limb. The right CFA was punctured using an ipsilateral approach and the Angio-Seal was used for hemostasis. The Angio-Seal collagen with the footplate dropped into the bifurcation of the deep femoral artery. The collagen and footplate were caught with MBF and pulled up to the EIA. The right CFA was punctured and a 10.0- × 60-mm stent (SMART®; Cordis) was delivered from the ipsilateral sheath. The stent was deployed at the EIA and crushed the collagen with the footplate. Conclusions: MBF were used to grasp the dislodged collagen with the anchor and cover it with a stent at the iliac artery. This may be a useful bailout technique for Angio-Seal dislodgement.
- 5 October 2024
- Published by Springer Nature in CVIR Endovascular
- Vol. 7 (1) , 1-6
Open AccessA novel bailout technique using myocardial biopsy forceps to grasp a dislodged angio-seal collagen with footplate
Background: Hemostatic devices are now frequently used in femoral artery punctures, and the Angio-Seal (Terumo, Tokyo, Japan) is one of the most commonly used devices for closure of the femoral artery because it provides rapid hemostasis. Although device failure rarely occurs, if the collagen falls into the femoral artery, it may lead to severe limb ischemia. Herein, we describe a case of a novel endovascular technique for the treatment of Angio-Seal arterial closure device failure. Case presentation: The patient in Case 1 was a 75-year-old man with severe left limb claudication. We used a contralateral antegrade approach and used the Angio-Seal for hemostasis. However, the Angio-Seal collagen and footplate dropped and stopped at the bifurcation of the superficial femoral artery and deep femoral artery. The collagen with the footplate was caught with myocardial biotome forceps (MBF) and pulled into the external iliac artery (EIA). The distal common femoral artery (CFA) was punctured, and we delivered a 10.0- × 80-mm stent (SMART®; Cordis, USA) to the EIA from the ipsilateral sheath. The stent was deployed at the EIA and crushed the collagen. The patient in Case 2 was an 88-year-old man with rest pain in the right limb. The right CFA was punctured using an ipsilateral approach and the Angio-Seal was used for hemostasis. The Angio-Seal collagen with the footplate dropped into the bifurcation of the deep femoral artery. The collagen and footplate were caught with MBF and pulled up to the EIA. The right CFA was punctured and a 10.0- × 60-mm stent (SMART®; Cordis) was delivered from the ipsilateral sheath. The stent was deployed at the EIA and crushed the collagen with the footplate. Conclusions: MBF were used to grasp the dislodged collagen with the anchor and cover it with a stent at the iliac artery. This may be a useful bailout technique for Angio-Seal dislodgement.